Nanosynth shares upside encouraging results from trials to integrate technology
By Joe Hoppe
Shares of Nanosynth Group PLC rose on Wednesday after announcing successful trial results with Volz Holdings vos, allowing it to integrate its antiviral technology into heating, ventilation and air conditioning, or HVAC, units.
Shares at 0715 GMT were up 0.1 pence, or 19%, at 0.62 pence.
The London-listed nanomaterials company said the results will enable the two companies to develop a standard upgrade to its media production lines. Following the latest production trial, its partner Volz is currently implementing process improvements to enable more efficient and consistent production of secure and reliable media for end users.
Nanosynth said on July 4 that it plans to take technology developed with Volz and use it directly in mounts for masks and other products in the HVAC market.
The UK’s Health and Safety Executive has completed all checks and approved a subsidiary of Nanosynth for REACH registration, allowing it to produce and distribute up to 100 metric tonnes of copper oxide nanomaterial per year, said said the company. This will allow Nanosynth to expand rapidly into antipathogen products outside of the HVAC antiviral market, he said.
“A pipeline of interest is already at an advanced stage, and we hope this will lead to significant sales for our first antiviral product to market,” said chief executive Mark Duffin.
Write to Joe Hoppe at [email protected]